Cannabis oil and other derivatives from the marijuana plant have been around for some time now, but with new methods of research and a growing legal market, it seems that cannabis oils are bigger than ever. The cannabis market has been growing in legality in North America and around the world over the course of the past several years, and the new legal state of the plant has meant that more companies than ever are looking into how they begin to produce large amounts of cannabis oils.

First off, cannabis oils are the extracted chemicals from the cannabis plant, which when unprocessed contain around 100 or so active ingredients which all combine to help give many of the medical benefits of smoking cannabis in its natural form. According to one report “The two main active substances in cannabis plants are cannabidiol, or CBD, and delta-9 tetrahydrocannabinol, or THC. Oil extracted from hemp plants can contain a lot of CBD, while oil from skunk plants will contain far more THC. THC produces the high that recreational cannabis users seek, while oils for medical use contain mostly CBD.”

One of the most prominent reasons to use cannabis oils and extracts is the fact that the dosing is much easier to control and monitor as opposed to dried cannabis. The amounts of THC and CBD in the plant are very easily controlled in this method, and thus this information can be given to the patient to help ensure that they are getting the most quality medicine with the correct information.

In terms of medicinal benefits, the two main components of cannabis, THC, and CBD both have their own varying properties. CBD can work as an anticonvulsant, which means that it can be used to help reduce the frequency of seizures. CBD also has no psychoactive properties, which means that it does not get the user high. This helps to make the case for CBD being a promising treatment for children who have epileptic seizures but want an alternative to the traditional harsh pharmaceuticals that are often prescribed.

The industry on cannabis extracts has also been working to merge this with that of the pharmaceutical market. Many big companies have been researching new ways to include cannabis oils in pharmaceuticals to help with a wide variety of conditions and ailments. In recent news, the Food and Drug Administration will be considering whether or not to approve the drug Epidiolex, which is a CBD-derived medicine that can help to fight seizures. Around the world, many governments have been working to attempt to find some sort of legalization or fair legislation that would allow these patients to get the help that they need. The European Medicines Agency is scheduled to state a ruling on whether or not the drug should be legalized within the European Union, but that is all that has been said up to this point.

Cannabis oil has also been making its way into the most prominent aspects of the cannabis industry. Many companies have realized how lucrative these oils can be, and have thus begun producing it in quite large amounts. Canada has become one of the largest producers of cannabis-derived oils and only looks as though they will continue on this streak in the future. The hopes are high that the market for cannabis can continue to produce new medicines that help individuals with a wide variety of conditions. Only time will tell how the effect of the mass-production of these oils will help to make the market more broad in terms of product in the near future.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

*UPDATED* Timing in Marijuana Stocks is Everything & Our Time is Tuesday February 18, 2020, @ 9:45 am EST!

Tuesday, February 18, 2020, @ 9:45 am EST we will be announcing…

Marijuana Stocks – The Current State of the Cannabis Sector from the Wolf of Weed Street aka Jason Spatafora

The Current State of the Cannabis Sector As we’ve begun 2020 after…